Literature DB >> 19050066

Treatment of older adults with acute myeloid leukemia: state of the art and current perspectives.

Mikkael A Sekeres.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19050066     DOI: 10.3324/haematol.2008.000497

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  18 in total

1.  Senior adult oncology.

Authors:  Arti Hurria; Ilene S Browner; Harvey Jay Cohen; Crystal S Denlinger; Mollie deShazo; Martine Extermann; Apar Kishor P Ganti; Jimmie C Holland; Holly M Holmes; Mohana B Karlekar; Nancy L Keating; June McKoy; Bruno C Medeiros; Ewa Mrozek; Tracey O'Connor; Stephen H Petersdorf; Hope S Rugo; Rebecca A Silliman; William P Tew; Louise C Walter; Alva B Weir; Tanya Wildes
Journal:  J Natl Compr Canc Netw       Date:  2012-02       Impact factor: 11.908

Review 2.  Small molecule inhibitors in acute myeloid leukemia: from the bench to the clinic.

Authors:  Muneera Al-Hussaini; John F DiPersio
Journal:  Expert Rev Hematol       Date:  2014-08       Impact factor: 2.929

3.  Impact of chemotherapy delay on short- and long-term survival in younger and older AML patients: a Danish population-based cohort study.

Authors:  L S G Ostgard; J M Nørgaard; H Sengeløv; M S Holm; M K Jensen; M Kallenbach; C W Marcher; O J Nielsen; M Nørgaard
Journal:  Leukemia       Date:  2014-05-12       Impact factor: 11.528

4.  Expression of Eph A4, Eph B2 and Eph B4 receptors in AML.

Authors:  Tomasz Wrobel; Joanna Pogrzeba; Ewa Stefanko; Marcin Wojtowicz; Bozena Jazwiec; Justyna Dzietczenia; Grzegorz Mazur; Kazimierz Kuliczkowski
Journal:  Pathol Oncol Res       Date:  2014-04-25       Impact factor: 3.201

Review 5.  Dendritic Cells of Leukemic Origin: Specialized Antigen-Presenting Cells as Potential Treatment Tools for Patients with Myeloid Leukemia.

Authors:  Daniel Christoph Amberger; Helga Maria Schmetzer
Journal:  Transfus Med Hemother       Date:  2020-11-05       Impact factor: 3.747

6.  Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemia.

Authors:  Peter Herhaus; Stefan Habringer; Kathrin Philipp-Abbrederis; Tibor Vag; Carlos Gerngross; Margret Schottelius; Julia Slotta-Huspenina; Katja Steiger; Torben Altmann; Tanja Weißer; Sabine Steidle; Markus Schick; Laura Jacobs; Jolanta Slawska; Catharina Müller-Thomas; Mareike Verbeek; Marion Subklewe; Christian Peschel; Hans-Jürgen Wester; Markus Schwaiger; Katharina Götze; Ulrich Keller
Journal:  Haematologica       Date:  2016-05-12       Impact factor: 9.941

Review 7.  New and emerging therapies for acute myeloid leukaemia.

Authors:  Julian R Davis; David J Benjamin; Brian A Jonas
Journal:  J Investig Med       Date:  2018-08-19       Impact factor: 2.895

8.  Comparison of epigenetic versus standard induction chemotherapy for newly diagnosed acute myeloid leukemia patients ≥60 years old.

Authors:  Neha Gupta; Austin Miller; Shipra Gandhi; Laurie A Ford; Carlos E Vigil; Elizabeth A Griffiths; James E Thompson; Meir Wetzler; Eunice S Wang
Journal:  Am J Hematol       Date:  2015-07       Impact factor: 10.047

9.  Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination.

Authors:  Viggo F Van Tendeloo; Ann Van de Velde; Ann Van Driessche; Nathalie Cools; Sébastien Anguille; Kristin Ladell; Emma Gostick; Katrien Vermeulen; Katrien Pieters; Griet Nijs; Barbara Stein; Evelien L Smits; Wilfried A Schroyens; Alain P Gadisseur; Inge Vrelust; Philippe G Jorens; Herman Goossens; I Jolanda de Vries; David A Price; Yusuke Oji; Yoshihiro Oka; Haruo Sugiyama; Zwi N Berneman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-14       Impact factor: 11.205

Review 10.  Management of Relapsed/Refractory Acute Myeloid Leukemia in the Elderly: Current Strategies and Developments.

Authors:  Jeffrey C Bryan; Elias J Jabbour
Journal:  Drugs Aging       Date:  2015-08       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.